Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

被引：0

作者：

Kohei Shitara

Toshihiko Doi

Hisashi Hosaka

Peter Thuss-Patience

Armando Santoro

Federico Longo

Ozgur Ozyilkan

Irfan Cicin

David Park

Aziz Zaanan

Carles Pericay

Mustafa Özgüroğlu

Maria Alsina

Lukas Makris

Karim A. Benhadji

David H. Ilson

机构：

[1] National Cancer Center Hospital East,Department of Gastrointestinal Oncology

[2] Gunma Prefectural Cancer Center,Department of Gastroenterology

[3] Charité-Universitätsmedizin Berlin,Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie

[4] Humanitas University,Department of Biomedical Sciences

[5] IRCCS Humanitas Research Hospital,Medical Oncology

[6] Humanitas Cancer Center,Medical Oncology

[7] Hospital Universitario Ramon y Cajal,Department of Internal Medicine, Division of Medical Oncology, School of Medicine

[8] IRYCIS,Hematology and Oncology

[9] CIBERONC,Department of Gastrointestinal Oncology, European Georges Pompidou Hospital, AP

[10] Baskent University Adana Practice and Research Centre Kisla,HP Centre

[11] Trakya University,Medical Oncology

[12] St. Jude Crosson Cancer Institute/St. Joseph Heritage Healthcare,Department of Internal Medicine, Division of Medical Oncology, Clinical Trial Unit, Cerrahpaşa School of Medicine

[13] University of Paris,Medical Oncology Department

[14] Corporación Sanitaria Parc Tauli,Clinical Development

[15] Istanbul University-Cerrahpaşa,Gastrointestinal Oncology Service in the Department of Medicine

[16] Vall d’Hebron Institute of Oncology (VHIO),undefined

[17] Stathmi,undefined

[18] Inc.,undefined

[19] Taiho Oncology,undefined

[20] Inc.,undefined

[21] Memorial Sloan Kettering Cancer Center,undefined

来源：

Gastric Cancer | 2022年 / 25卷

关键词：

Stomach neoplasms; Gastrointestinal neoplasms; Trifluridine tipiracil; Age groups; Aged; Randomized controlled trial;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：586 / 597

页数：11

共 117 条

[1]

Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2]

Ferlay J(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300

[3]

Siegel RL(2016)Chemotherapy in elderly patients with gastric cancer J Cancer 7 88-94

[4]

Laversanne M(2018)Postoperative morbidity in elderly patients after gastric cancer surgery Ann Gastroenterol 31 621-627

[5]

Soerjomataram I(2013)Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients Ann Surg Oncol 20 371-380

[6]

Jemal A(2017)Increasing survival gap between young and elderly gastric cancer patients Gastric Cancer 20 919-928

[7]

Jemal A(2010)Gastric cancer in the elderly: an overview Eur J Surg Oncol 36 709-717

[8]

Siegel R(2004)A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA Int J Oncol 25 571-578

[9]

Xu J(2004)An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA Int J Mol Med 13 249-255

[10]

Ward E(2017)Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application Oncotarget 8 16052-16074

← 1 2 3 4 5 6 7 8 9 10 →